the other point is about some references. Figure 2a showed a graphic representation of approximated Ct DNA prevalence (%) in hPV-positive women, cervical neoplasia and/or invasive cervical cancer observed in some countries around the world. Look at references 62 and 70, both were cited as Brazilian studies but the analysis was conducted on Indians; another reference (69) described Colombian and not Brazilian patients. Although the merit of the paper is its expressiveness, I think these wrong citations must be corrected.
Dear editor,
Chlamydia trachomatis (Ct) and human papillomaviruses (hPV) may contribute to the development of cervical intraepithelial neoplasia (CIN) [1] . the association between hPV and bacterial vaginosis (BV) was described in pregnant women [2] or non-pregnant women [3] . One explication is host immune response variation [1] . Vaginal ph >4.5 is another possibility found in cases of association between BV and hPV [2] . the review of Silva et al. [1] recently published in Arch Gynecol Obstet show studies about possible association between Ct and hPV. the review is well conducted; nonetheless, two points could be addressed. First, the possible association among hPV, Ct and BV must be discussed. In a meta-analysis [3] , 12 eligible studies were selected to review the association between BV and hPV (total of 6,372 women). the overall estimated odds ratio (Or) showed a positive association between BV and cervical hPV infection (Or 1.43; 95 % confidence interval 1.11-1.84). Other study [2] in pregnant women on association among hPV, Ct and BV showed that compared to the group of pregnant women without hPV infection, those with hPV infection had a higher prevalence of BV (53.8 vs. 15.4 %; p = 0.007), and Ct (34.6 vs. 7.7 %; p = 0.039). All cases of Ct and BV had high-grade hPV infection.
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